Recent Finacing
Recent Raise
Gem Pharmaceuticals is a Birmingham, AL–based clinical-stage biopharmaceutical company developing GPX-150, an anthracycline derivative engineered to reduce cardiotoxicity while preserving anti-cancer activity, advancing to Phase 2 sarcoma trials.
Focus Areas
Total Raised
Funding round